Enveric Biosciences, Inc. (ENVB)

0.2126 -0.0017 (-0.79%) At close: 04:00PM EDT

Enveric Biosciences, Inc.

4851 Tamiami Trail North
Suite 200
Naples, FL 34103
United States
239 302 1707
https://www.enveric.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 23

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Ian Johnson	Exec. Chairman	418.75k	N/A	1958
Dr. Joseph Edward Tucker Ph.D.	CEO & Director	474.82k	N/A	1969
Mr. Avani V. Kanubaddi	Pres & COO	447.07k	N/A	1973
Mr. Carter J. Ward CPA, CSCP	Chief Financial Officer	N/A	N/A	1964
Dr. Peter J. Facchini Ph.D.	Chief Innovation Officer	303.52k	N/A	1964
Dr. Ibrahim Dagher M.D.	Chief Medical Officer	N/A	N/A	1969

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Corporate Governance

Enveric Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.